Cadence Biomedical is a privately held early stage medical device company whose mission is to improve mobility for people with disabilities. The company's flagship kinetic orthosis product is a revolutionary device that can provide assistance to muscles and help people with severe disabilities walk.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/19/12 | $750,000 | Series A-2 |
Alliance of Angels Frontier Angel Fund HealthTech Capital Keiretsu Forum Northwest Wings | undisclosed |
